Association between genetic polymorphisms and ovarian cancer risk

Anticancer Research

Volumn 28, Issue 5 B, 2008, Pages 3079-3081

  Delort, Laetitia ^a,b,c   Chalabi, Nasséra ^a,b,c   Satih, Samir ^a,b,c   Rabiau, Nadège ^a,b,c   Kwiatkowski, Fabrice ^a   Bignon, Yves Jean ^a,b,c   Bernard Gallon, Dominique J ^a,b,c  

^a CENTRE JEAN PERRIN   (France)

^b CRNH AUVERGNE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Estrogen and xenobiotic metabolism; Ovarian cancer; Polymorphisms

Indexed keywords

CARRIER PROTEIN; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ESTROGEN; ESTROGEN RECEPTOR; GLUTATHIONE TRANSFERASE P1; PROGESTERONE RECEPTOR; PROTEIN NAT2; UNCLASSIFIED DRUG;

ACETYLATOR PHENOTYPE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; ESTROGENS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; XENOBIOTICS;

EID: 55749105394     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Tretarre B, Remontet L, Menegoz F et al: Ovarian cancer: incidence and mortality in France. J Gynecol Obstet Biol Reprod (Paris) 34: 154-161, 2005.
2. Fathalla MF: Incessant ovulation-a factor in ovarian neoplasia? Lancet 2: 163, 1971.
3. Lukanova A and Kaaks R: Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 14: 98-107, 2005.
4. Cheng TC, Chen ST, Huang CS et al: Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113: 345-353, 2005.
5. Mitrunen K and Hirvonen A: Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 544: 9-41, 2003.
6. Kwiatkowski F, Girard M, Hacène K and Berlie J: Sem: a suitable statistical software adaptated for research in oncology. Bull Cancer 87: 715-721, 2000.
7. Goodman MT, McDuffie K, Kolonel LN et al: Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev 10: 209-216, 2001.
8. Holt SK, Rossing MA, Malone KE, Schwartz SM, Weiss NS and Chen C: Ovarian cancer risk and polymorphisms involved in estrogen catabolism. Cancer Epidemiol Biomarkers Prev 16: 481-489, 2007.
9. Sellers TA, Schildkraut JM, Pankratz VS et al: Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Cancer Epidemiol Biomarkers Prev 14: 2536-2543, 2005.